Supporting the Next Generation of Scientists to Lead Cancer Immunology Research.


Journal

Cancer immunology research
ISSN: 2326-6074
Titre abrégé: Cancer Immunol Res
Pays: United States
ID NLM: 101614637

Informations de publication

Date de publication:
11 2021
Historique:
received: 30 06 2021
revised: 23 08 2021
accepted: 13 09 2021
pubmed: 22 9 2021
medline: 17 3 2022
entrez: 21 9 2021
Statut: ppublish

Résumé

Recent success in the use of immunotherapy for a broad range of cancers has propelled the field of cancer immunology to the forefront of cancer research. As more and more young investigators join the community of cancer immunologists, the Arthur L. Irving Family Foundation Cancer Immunology Symposium provided a platform to bring this expanding and vibrant community together and support the development of the future leaders in the field. This commentary outlines the lessons that emerged from the inaugural symposium highlighting the areas of scientific and career development that are essential for professional growth in the field of cancer immunology and beyond. Leading scientists and clinicians in the field provided their experience on the topics of scientific trajectory, career trajectory, publishing, fundraising, leadership, mentoring, and collaboration. Herein, we provide a conceptual and practical framework for career development to the broader scientific community.

Identifiants

pubmed: 34544686
pii: 2326-6066.CIR-21-0519
doi: 10.1158/2326-6066.CIR-21-0519
pmc: PMC9644410
mid: NIHMS1746345
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1245-1251

Subventions

Organisme : NCI NIH HHS
ID : K99 CA248953
Pays : United States
Organisme : Intramural NIH HHS
ID : Z99 AI999999
Pays : United States

Informations de copyright

©2021 The Authors; Published by the American Association for Cancer Research.

Références

Med Educ. 2003 Apr;37(4):376-85
pubmed: 12654123
Ann Intern Med. 2005 Feb 15;142(4):274-82
pubmed: 15710960
Paediatr Respir Rev. 2012 Mar;13(1):63-6
pubmed: 22208796
PLoS One. 2015 Mar 04;10(3):e0118494
pubmed: 25738742

Auteurs

Elise Alspach (E)

Department of Molecular Microbiology and Immunology, Saint Louis University, St. Louis, Missouri.

Ryan D Chow (RD)

Department of Genetics, Yale University School of Medicine, New Haven, Connecticut.

Shadmehr Demehri (S)

Center for Cancer Immunology and Cutaneous Biology Research Center, Department of Dermatology, Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts. SDEMEHRI1@mgh.harvard.edu.

Jennifer L Guerriero (JL)

Department of Surgery, Division of Breast Surgery, Brigham and Women's Hospital, Boston, Massachusetts.

Shashi Gujar (S)

Department of Pathology, Microbiology and Immunology, and Biology, Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada.

Felix J Hartmann (FJ)

Department of Pathology, School of Medicine, Stanford University, Palo Alto, California.

Beth A Helmink (BA)

Department of Surgery, Washington University School of Medicine, St. Louis, Missouri.

William H Hudson (WH)

Emory Vaccine Center and Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia.

Won Jin Ho (WJ)

Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.

Leyuan Ma (L)

Koch Institute for Integrative Cancer Research and Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts.

Barbara B Maier (BB)

CeMM-Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.

Vivien I Maltez (VI)

Lymphocyte Biology Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda; National Institute of General Medical Sciences, National Institutes of Health, Bethesda, Maryland.

Brian C Miller (BC)

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston; Evergrande Center for Immunological Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston; Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, Massachusetts.

Amy E Moran (AE)

Department of Cell, Developmental and Cancer Biology, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon.

Erin M Parry (EM)

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston; Harvard Medical School, Boston, Massachusetts.

Padmini S Pillai (PS)

Koch Institute for Integrative Cancer Research and Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts.

Sarwish Rafiq (S)

Winship Cancer Institute and Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, Georgia.

Miguel Reina-Campos (M)

Division of Biological Sciences, Section of Molecular Biology, University of California, San Diego, La Jolla, California.

Pamela C Rosato (PC)

Department of Microbiology and Immunology, The Geisel School of Medicine at Dartmouth College, Lebanon, New Hampshire.

Nils-Petter Rudqvist (NP)

Department of Thoracic/Head and Neck Medical Oncology and Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Megan K Ruhland (MK)

Department of Cell, Developmental and Cancer Biology, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon.

Idit Sagiv-Barfi (I)

Division of Oncology, Department of Medicine, Stanford University, Stanford, California.

Avinash Das Sahu (AD)

Department of Data Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts.

Robert M Samstein (RM)

Department of Radiation Oncology, Precision Immunology Institute, Icahn School of Medicine at Mount Sinai Hospital, New York, New York.

Christian M Schürch (CM)

Department of Pathology and Neuropathology, University Hospital and Comprehensive Cancer Center Tübingen, Tübingen, Germany.

Debattama R Sen (DR)

Department of Medicine and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.

Daniela S Thommen (DS)

Division of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.

Yochai Wolf (Y)

Evergrande Center for Immunologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

Roberta Zappasodi (R)

Weill Cornell Medicine, Weill Cornell Medical College, New York; Parker Institute for Cancer Immunotherapy; Memorial Sloan Kettering Cancer Center, New York, New York.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH